Colgate-Palmolive Analysts Slash Their Forecasts After Q4 Results
Colgate-Palmolive Company CL posted mixed results for the fourth quarter on Friday.
Why Colgate-Palmolive Stock Fell Today
Shares of Colgate-Palmolive (CL -4.61%) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.
Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs
Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co CL with a price forecast of $106.
Colgate Q4 Earnings Beat, Strong Volume and Pricing Drive Results
CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions. Improved gross margins aid EPS growth.
Colgate-Palmolive Stock Falls as Foreign Exchange Rates Hurt Sales, Outlook
Colgate-Palmolive (CL) shares fell 5% Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.
Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment
Toothpaste and manual toothbrushes market leader Colgate-Palmolive Company released its fourth quarter and full-year 2024 results today. Judging by the share price reaction, and considering CL stock is down more than 20% from its all-time high, this clearly looks like a “buy the dip” moment. However, I'll explain why I don't think it's a good idea to buy CL shares, either for dividend or total return investors, and despite the company's undoubtedly solid 2024 performance.
Colgate-Palmolive Company (CL) Q4 2024 Earnings Call Transcript
Colgate-Palmolive Company (NYSE:CL ) Q4 2024 Earnings Conference Call January 31, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive Vice President, M&A Noel Wallace - Chairman, President and Chief Executive Officer Stanley Sutula - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Bonnie Herzog - Goldman Sachs Andrea Teixeira - JPMorgan Kaumil Gajrawala - Jefferies Kevin Grundy - BNP Bryan Spillane - Bank of America Olivia Tong - Raymond James Sergio Matsumoto - TD Cowen Christopher Carey - Wells Fargo Stephen Powers - Deutsche Bank Lauren Lieberman - Barclays Robert Ottenstein - Evercore ISI Korinne Wolfmeyer - Piper Sandler Mark Astrachan - Stifel Filippo Falorni - Citi Edward Lewis - Redburn Atlantic Operator Good morning. Welcome to today's Colgate-Palmolive 2024 Fourth Quarter and Year End Earnings Conference Call.
Colgate-Palmolive (CL) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Colgate-Palmolive (CL) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Colgate-Palmolive EPS Up, Revenue Lags
Consumer goods manufacturer Colgate-Palmolive (CL -5.19%) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91, surpassing Wall Street consensus estimates of $0.89.
Colgate-Palmolive (CL) Q4 Earnings Surpass Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.87 per share a year ago.
Colgate-Palmolive's stock slips on weaker-than-expected guidance despite Q4 profit beat
Colgate-Palmolive's CEO noted that the company hit an “exciting milestone,” but it wasn't enough to lift the stock premarket.
Colgate-Palmolive sees weaker annual sales on demand slowdown
Toothpaste maker Colgate-Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales estimates on Friday, hurt by weak demand in North America and Latin America for its household products.
